cancer clinical trials in eugene, OR

Metastatic Breast Cancer, Advanced Breast Cancer, Advanced Gastric Cancer, Advanced/Metastatic Non-small Cell Lung Cancer, Gastrointestinal Stromal Tumor, Hepatocellular Carcinoma, Metastatic Castration-resistant Prostate Cancer, Metastatic Renal Cell Cancer, Non Small Cell Lung Cancer, Pancreatic Islet Cell Carcinoma, Pancreatic Neuroendocrine Tumor, Thyroid Cancer

A Study of Enzastaurin and Erlotinib in Patients With Solid Tumors and Lung Cancer

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Eugene, Oregon 97401

Non-Small Cell Lung Cancer

Adj TC + Herceptin Early Stage Breast Cancer

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Breast Cancer

TAC Versus TC for Adjuvant Breast Cancer

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Breast Cancer

A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease

Eugene, Oregon

Moderate Risk of CVD

Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Multiple Myeloma

Pre-op Rectal ChemoRad +/- Cetuximab

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Rectal Cancer

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Willamette Valley Cancer Center - Eugene
Eugene, Oregon 97401

Lung Cancer, Radiation Toxicity

Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors

Willamette Valley Cancer Center - Eugene
Eugene, Oregon 97401

Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

Willamette Valley Cancer Center - Eugene
Eugene, Oregon 97401

Prostate Cancer

A Study of R1507 in Patients With Recurrent or Refractory Sarcoma.

Eugene, Oregon

Sarcoma

Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer

Willamette Valley Cancer Center - Eugene
Eugene, Oregon 97401

Esophageal Cancer

Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Androgen-independent Prostate Cancer

Prospective Observational Epidemiologic Study of Maraviroc's Safety

Pfizer Investigational Site
Eugene, Oregon 97401

Human Immunodeficiency Virus

Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer

Pfizer Investigational Site
Eugene, Oregon 97401

Kidney Neoplasms

Sorafenib as Adjuvant Treatment in the Prevention Of Recurrence of Hepatocellular Carcinoma (STORM)

Eugene, Oregon

Carcinoma, Hepatocellular

Randomized Phase II Trial of Letrozole With or Without Dasatinib as First and Second-line Treatment for Hormone Receptor-positive, HER2-negative Post-menopausal Breast Cancer That is Unresectable, Locally Recurrent or Metastatic

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Metastatic Breast Cancer

A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue Sarcoma

Eugene, Oregon

Soft Tissue Sarcoma

Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Advanced Breast Cancer

Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer

Pfizer Investigational Site
Eugene, Oregon 97401

Advanced Breast Cancer, Breast Cancer

Gene Transfer for Cancer Pain

Pain Research of Oregon, LLC
Eugene, Oregon 97401

Cancer Pain

Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer

Willamette Valley Cancer Center - Eugene
Eugene, Oregon 97401

Endometrial Cancer, Fatigue, Neurotoxicity

Gemzar, Cisp, Sunitinib Urothelial Ca

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Urothelial Cancer

An Open-label Study of Trastuzumab Emtansine (T-DM1) vs Capecitabine + Lapatinib in Patients With HER2-positive Locally Advanced or Metastatic Breast Cancer

Eugene, Oregon

Breast Cancer

Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney Cancer

Pfizer Investigational Site
Eugene, Oregon 97401

Carcinoma, Renal Cell

Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Ovarian Cancer

Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

Pfizer Investigational Site
Eugene, Oregon 97401

Breast Cancer

Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma

Willamette Valley Cancer Center
Eugene, Oregon 97401-8122

Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma

Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer

Eugene, Oregon

Prostate Cancer

Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer

Pfizer Investigational Site
Eugene, Oregon 97401

Breast Cancer, Advanced Breast Cancer

Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer

Pfizer Investigational Site
Eugene, Oregon 97401

Kidney Neoplasms

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Willamette Valley Cancer Center - Eugene
Eugene, Oregon 97401

Prostate Cancer, Sexual Dysfunction

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Pfizer Investigational Site
Eugene, Oregon 97401

Carcinoma, Non-Small-Cell Lung

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Pfizer Investigational Site
Eugene, Oregon 97401

Carcinoma, Non-Small-Cell Lung

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

Willamette Valley Cancer Center - Eugene
Eugene, Oregon 97401

Prostate Cancer

COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial

Eugene, Oregon

Myelofibrosis

Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer

Willamette Valley Cancer Center - Eugene
Eugene, Oregon 97401

Head and Neck Cancer

Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

Eugene, Oregon

Castration-Resistant Prostate Cancer

A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Pfizer Investigational Site
Eugene, Oregon 97401

Solid Tumor, Kidney Neoplasms, Advanced Renal Cell Carcinoma

Nexavar® Versus Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

Eugene, Oregon

Thyroid Neoplasms

A Study of Advanced or Metastatic Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Eugene, Oregon

Carcinoma, Non-Small-Cell Lung

A Study of RO5185426 in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)

Eugene, Oregon

Malignant Melanoma

A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+RO5072759 (GA101) in Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)

Eugene, Oregon

Non-Hodgkin's Lymphoma

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Willamette Valley Cancer Center - Eugene
Eugene, Oregon 97401

Brain and Central Nervous System Tumors

A Study in Head and Neck Cancer

Head and Neck Neoplasms

Novel Determinants and Measures of Smokeless Tobacco Use: Study 1

Oregon Research Institute
Eugene, Oregon 97403

Smokeless Tobacco Use, Tobacco Dependence

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

US Oncology - Willamette Valley Cancer Institute - Eugene
Eugene, Oregon 97401-8122

Chronic Lymphocytic Leukemia

Connect® MM- The Multiple Myeloma Disease Registry

US Oncology - Willamette Valley Cancer Institute - Eugene
Eugene, Oregon 97401-8122

Multiple Myeloma

A Study in Head and Neck Cancer

Head and Neck Cancer

A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Eugene, Oregon

Castrate-Resistant Prostate Cancer, Hormone Refractory Prostate Cancer

Eribulin Mesylate in Combination With Intermittent Erlotinib in Patients With Previously Treated, Advanced Non-Small Cell Lung Cancer

Eugene, Oregon

Non-small Cell Lung Cancer

Study of E7080 in Subjects With Advanced Endometrial Cancer and Disease Progression

Eugene, Oregon

Endometrial Cancer

A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer (MARIANNE)

Eugene, Oregon

Breast Cancer

An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Pfizer Investigational Site
Eugene, Oregon 97401

Neoplasms Malignant

An Open-Label, 2-Cohort, Multicenter, Study of E7080 in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma

Eugene, Oregon

Unresectable Stage III or Stage IV Melanoma

Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

Eugene, Oregon

Pediatric Acute Myelogenous Leukemia (AML)

A Study in Second Line Metastatic Colorectal Cancer

Colorectal Cancer

Study Comparing Orteronel Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer

Eugene, Oregon

Prostate Cancer

Study of CX-4945 in Patients With Relapsed or Refractory Multiple Myeloma

Eugene, Oregon

Multiple Myeloma

A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma

Eugene, Oregon

Chronic Lymphocytic Leukemia, Non-Hodgkin's Lymphoma

A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer

Eugene, Oregon

Prostate Cancer

Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer

Eugene, Oregon

Prostate Neoplasms, Genital Neoplasms, Male, Urogenital Neoplasms, Genital Diseases, Male

Join the directory

Join the Community

Join the Directory